BioMarin Pharmaceutical Inc.
Cheryl is currently the head of the European medical writing group for BioMarin, and specialises in medical writing for serious and life‑threatening rare diseases. She joined the pharmaceutical industry in 2001 in drug development, and continued in positions in medical editing and medical writing in both the pharmaceutical and consultancy industry. She holds a degree in Medical Biology and a Masters in Neuroscience. Cheryl has been a workshop leader since 2015.